Skip to main content
SpringerLink
Log in

Diagnosis and management of acute movement disorders

  • ENS TEACHING REVIEW
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Most movement disorders, reflecting degenerative disorders, develop in a slowly progressive fashion. Some movement disorders, however, manifest with an acute onset. We wish to give an overview of the management and therapy of those acute-onset movement disorders.

Drug–induced movement disorders are mainly caused by dopamine–receptor blockers (DRB) as used as antipsychotics (neuroleptics) and antiemetics. Acute dystonic reactions usually occur within the first four days of treatment. Typically, cranial pharyngeal and cervical muscles are affected. Anticholinergics produce a prompt relief.Akathisia is characterized by an often exceedingly bothersome feeling of restlessness and the inability to remain still. It is a common side effect of DRB and occurs within few days after their initiation. It subsides when DRB are ceased.Neuroleptic Malignant Syndrome is a rare, but life–threatening adverse reaction to DRB which may occur at any time during DRB application. It is characterised by hyperthermia, rigidity, reduced consciousness and autonomic failure. Therapeutically immediate DRB withdrawal is crucial.Additional dantrolene or bromocriptine application together with symptomatic treatment may be necessary.

Paroxysmal dyskinesias are childhood onset disorders characterised by dystonic postures, chorea, athetosis and ballism occurring at irregular intervals. In Paroxysmal Kinesigenic Dyskinesia they are triggered by rapid movements, startle reactions or hyperventilation. They last up to 5 minutes, occur up to 100 times per day and are highly sensitive to anticonvulsants. In Paroxysmal Non–Kinesiogenic Dyskinesia they cannot be triggered, occur less frequently and last longer.Other paroxysmal dyskinesias include hypnogenic paroxysmal dyskinesias, paroxysmal exertional dyskinesia, infantile paroxysmal dystonias, Sandifer's syndrome and symptomatic paroxysmal dyskinesias.

In Hereditary Episodic Ataxia Type 1 attacks of ataxia last for up to two minutes, may be accompanied by dysarthria and dystonia and usually respond to phenytoin. In Type 2 they can last for several hours, may be accompanied by vertigo, headache and malaise and usually respond to acetazolamide. Symptomatic episodic ataxias can occur in a number of metabolic disorders, but also in multiple sclerosis and Behcet's disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Addonizio G, Susman VL, Roth SD (1987) Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry 22:1004–1020

    Article  PubMed  CAS  Google Scholar 

  2. Akman–Demir FG, Eraksoy M, Gurvit IH, Saruhan–Direskeneli G, Aral O (1995) Paroxysmal dysarthria and ataxia in a patient with Behcet's disease. J Neurol 242:344–347

    Article  PubMed  CAS  Google Scholar 

  3. Angelini L, Rumi V, Lamperti E, Nardocci N (1988) Transient paroxysmal dystonia in infancy. Neuropediatrics 19:171–174

    PubMed  CAS  Google Scholar 

  4. Auburger G, Ratzlaff T, Lunkes A, Nelles HW, Leube B, Binkofski F, Kugel H, Heindel W, Seitz R, Benecke R, Witte OW, Voit T (1996) A gene for autosomal dominant paroxysmal choreoathetosis/ spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 31:90–94

    Article  PubMed  CAS  Google Scholar 

  5. Ayd FJ Jr (1961) A survey of drug–induced extrapyramidal reactions. JAMA 175:1054–1060

    PubMed  CAS  Google Scholar 

  6. Bain PG, Larkin GB, Calver DM, O'Brien MD (1991) Persistent superior oblique paresis as a manifestation of familial periodic cerebellar ataxia. Br J Ophthalmol 75:619–621

    Article  PubMed  CAS  Google Scholar 

  7. Bain PG, O'Brien MD, Keevil SF, Porter DA (1992) Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann Neurol 31:147–154

    Article  PubMed  CAS  Google Scholar 

  8. Baron DN, Dent CE, Harris H, Hart EW, Jepson JB (1956) Hereditary pellagra– like skin rash with temporary cerebellar ataxia, constant renal amino–aciduria, and other bizarre biochemical features. Lancet 271(6940):421–428

    Article  PubMed  CAS  Google Scholar 

  9. Bateman DN, Darling WM, Boys R, Rawlins MD (1989) Extrapyramidal reactions to metoclopramide and prochlorperazine. Q J Med 264:307–311

    Google Scholar 

  10. Berardi D, Amore M, Keck PE Jr, Troia M, Dell'Atti M (1998) Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case control study. Biol Psychiatry 44:748–754

    Article  PubMed  CAS  Google Scholar 

  11. Blaisdell GD (1994) Akathisia: a comprehensive review and treatment summary. Pharmacopsychiatry 27:139–146

    Article  PubMed  CAS  Google Scholar 

  12. Blass JP, Avigan J, Uhlendorf BW (1970) A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 49:423–432

    Article  PubMed  CAS  Google Scholar 

  13. Boyer WF, Bakalar NH, Lake CR (1987) Anticholinergic prophylaxis of acute haloperidol–induced acute dystonic reactions. J Clin Psychopharmacol 7:164–166

    PubMed  CAS  Google Scholar 

  14. Braude WM, Barnes TR, Gore SM (1983) Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions. Br J Psychiatry 143:139–150

    Article  PubMed  CAS  Google Scholar 

  15. Brody AL (1996) Acute dystonia induced by rapid increase in risperidone dosage. J Clin Psychopharmacol 16:461–462

    Article  PubMed  CAS  Google Scholar 

  16. Caroff SN, Mann SC (1993) Neuroleptic malignant syndrome. Med Clin North Am 77:185–202

    PubMed  CAS  Google Scholar 

  17. Chong SA, Tan CH (1996) Fluvoxamine and akathisia. J Clin Psychopharmacol 16:334–335

    Article  PubMed  CAS  Google Scholar 

  18. Dancis J, Hutzler J, Rokkones T (1967) Intermittent branched–chain ketonuria. Variant of maple–syrup–urine disease. N Engl J Med 276:84–89

    Article  PubMed  CAS  Google Scholar 

  19. Daras M, Koppel BS, Atos–Radzion E (1994) Cocaine–induced choreoathetoid movements ('crack dancing'). Neurology 44:751–752

    PubMed  CAS  Google Scholar 

  20. Delay J, Pichot P, Lemperiere T, Elissade B, Peigne F (1960) Un neuroleptique majeur non–phenothiazine et non reserpinique, l'haloperidol, dans le traitement des psychoses. Annales Medico–Psychologique 118:145–152

    Google Scholar 

  21. Demirkiran M, Jankovic J (1995) Paroxysmal dyskinesias: Clinical features and classification. Ann Neurol 38:571–579

    Article  PubMed  CAS  Google Scholar 

  22. Dickey W (1991) The neuroleptic malignant syndrome. Prog Neurobiol 36:425–436

    Article  PubMed  CAS  Google Scholar 

  23. Duvoisin RC, Yahr MD (1965) Encephalitis and Parkinsonism. Arch Neurol 12:227–239

    PubMed  CAS  Google Scholar 

  24. Fahn S (1994) The paroxysmal dyskinesias. In:Marsden CD, Fahn S (eds) Movement Disorders 3. Butterworth–Heinemann, Oxford, pp 310–345

  25. Fink JK, Rainer S, Wilkowski J, Jones SM, Kume A, Hedera P, Albin R, Mathay J, Girbach L, Varvil T, Otterud B, Leppert M (1996) Paroxysmal dystonic choreoathetosis: tight linkage to chromosome 2q. Am J Hum Genet 59:140–145

    PubMed  CAS  Google Scholar 

  26. Fouad GT, Servidei S, Durcan S, Bertini E, Ptacek LJ (1996) A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q. Am J Hum Genet 59:135–139

    PubMed  CAS  Google Scholar 

  27. Gancher ST, Nutt JG (1986) Autosomal dominant episodic ataxia: a heterogeneous syndrome. Mov Disord 1:239–253

    Article  PubMed  CAS  Google Scholar 

  28. Garver DL, Davis DM, Dekirmenjian H, Ericksen S, Gosenfeld L, Haraszti J (1976) Dystonic reactions following neuroleptics: time course and proposed mechanisms. Psychopharmacologia 47:199–201

    Article  PubMed  CAS  Google Scholar 

  29. Gibb WR, Lees AJ (1986) The clinical phenomenon of akathisia. J Neurol Neurosurg Psychiatry 49:861–866

    Article  PubMed  CAS  Google Scholar 

  30. Gill J, Singh H, Nugent K (2003) Acute lithium intoxication and neuroleptic malignant syndrome. Pharmacotherapy 23:811–815

    Article  PubMed  Google Scholar 

  31. Gorard DA, Gibberd FB (1989) Paroxysmal dysarthria and ataxia: associated MRI abnormality. J Neurol Neurosurg Psychiatry 52:1444–1445

    PubMed  CAS  Google Scholar 

  32. Gowers WR (1885) Epilepsy and Other Chronic Convulsive Diseases. Their Cause, Symptoms, and Treatment. Dover, New York (reprint of 1885 edition), 1964:75–76

  33. Homan RW, Vasko MR, Blaw M (1980) Phenytoin plasma concentrations in paroxysmal kinesigenic choreoathetosis. Neurology 30:673–676

    PubMed  CAS  Google Scholar 

  34. Horner FH, Jackson LC (1969) Familial paroxysmal choreoathetosis. In: Barbeau A, Brunette JR (eds) Progress in Neuro–Genetics. Excerpta Medica Foundation, Amsterdam, pp 745–751

  35. Kastrup O, Gastpar M, Schwarz M (1994) Acute dystonia due to clozapine. J Neurol Neurosurg Psychiatry 57:119

    PubMed  CAS  Google Scholar 

  36. Kertesz A (1967) Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology 17:680–690

    PubMed  CAS  Google Scholar 

  37. Lance JW (1977) Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol 2:285–293

    Article  PubMed  CAS  Google Scholar 

  38. Lang AE, Johnson K (1987) Akathisia in idiopathic Parkinson's disease. Neurology 37:477–481

    PubMed  CAS  Google Scholar 

  39. Litt M, Kramer P, Browne D, Gancher S, Brunt ER, Root D, Phromchotikul T, Dubay CJ, Nutt J (1994) A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am J Hum Genet 55:702–709

    PubMed  CAS  Google Scholar 

  40. Lopez–Alemany M, Ferrer–Tuset C, Bernacer–Alpera B (1997) Akathisia and acute dystonia induced by sumatriptan. J Neurol 244:131–132

    Article  PubMed  CAS  Google Scholar 

  41. Lugaresi E, Cirignotta F (1981) Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome? Sleep 4:129–138

    PubMed  CAS  Google Scholar 

  42. Lugaresi E, Cirignotta F, Montagna P (1986) Nocturnal paroxysmal dystonia. J Neurol Neurosurg Psychiatry 49:375–380

    PubMed  CAS  Google Scholar 

  43. Marsden CD, Jenner P (1980) The pathophysiology of extrapyramidal side–effects of neuroleptic drugs. Psychol Med 10:55–72

    Article  PubMed  CAS  Google Scholar 

  44. Mazurek MF, Rosebush PI (1996) Circadian pattern of acute, neurolepticinduced dystonic reactions. Am J Psychiatry 153:708–710

    PubMed  CAS  Google Scholar 

  45. Miller CH, Hummer M, Oberbauer H, Kurzthaler I, DeCol C, Fleischhacker WW (1997) Risk factors for the development of neuroleptic induced akathisia. Eur Neuropsychopharmacol 7:51–55

    Article  PubMed  CAS  Google Scholar 

  46. Mount LA, Reback S (1940) Familial paroxysmal choreoathetosis. Arch Neurol Psychiat 44:841–847

    Google Scholar 

  47. Nonino F, Campomori A (1999) Neuroleptic malignant syndrome associated with metoclopramide. Ann Pharmacother 33:644–645

    Article  PubMed  CAS  Google Scholar 

  48. Plant G (1983) Focal paroxysmal kinesigenic choreoathetosis. J Neurol Neurosurg Psychiatry 46:345–348

    PubMed  CAS  Google Scholar 

  49. Poyurovsky M, Meerovich I, Weizman A (1995) Beneficial effect of low–dose mianserin on fluvoxamine–induced akathisia in an obsessive–compulsive patient. Int Clin Psychopharmacol 10:111–114

    PubMed  CAS  Google Scholar 

  50. Raja M, Azzoni A (2001) Novel antipsychotics and acute dystonic reactions. Int J Neuropsychopharmacol 4:393–397

    Article  PubMed  CAS  Google Scholar 

  51. Rosenberg MR, Green M (1989) Neuroleptic malignant syndrome. Review of response to therapy. Arch Intern Med 149:1927–1931

    Article  PubMed  CAS  Google Scholar 

  52. Rupniak NM, Jenner P, Marsden CD (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berl) 88:403–419

    Article  PubMed  CAS  Google Scholar 

  53. Sachdev P, Kruk J (1994) Clinical characteristics and predisposing factors in acute drug–induced akathisia. Arch Gen Psychiatry 51:963–974

    PubMed  CAS  Google Scholar 

  54. Sakkas P, Davis JM, Janicak PG, Wang ZY (1991) Drug treatment of the neuroleptic malignant syndrome. Psychopharmacol Bull 27:381–384

    PubMed  CAS  Google Scholar 

  55. Shahnawaz M, van der Westhuizen LR, Gledhill RF (2001) Episodic cervical dystonia associated with gastro–oesophageal reflux. A case of adult–onset Sandifer syndrome. Clin Neurol Neurosurg 103:212–215

    Article  PubMed  CAS  Google Scholar 

  56. Shalev A, Hermesh H, Munitz H (1988) The role of external heat load in triggering the neuroleptic malignant syndrome. Am J Psychiatry 145:110–111

    PubMed  CAS  Google Scholar 

  57. Shen WW (1981) Akathisia: an overlooked, distressing, but treatable condition. J Nerv Ment Dis 169:599–600

    PubMed  CAS  Google Scholar 

  58. Sicard JA (1923) Akathisia and tasikinesia. Presse Med (Paris) 31:265–266

    Google Scholar 

  59. Simpson GM, Lindenmayer JP (1997) Extrapyramidal symptoms in patients treated with risperidone. J Clin Psychopharmacol 17:194–201

    Article  PubMed  CAS  Google Scholar 

  60. Snyder CH (1969) Paroxysmal torticollis in infancy. Am J Dis Child 117:458–460

    PubMed  CAS  Google Scholar 

  61. Susman VL, Addonizio G (1988) Recurrence of neuroleptic malignant syndrome. J Nerv Ment Dis 176:234–241

    Article  PubMed  CAS  Google Scholar 

  62. Swett C Jr (1975) Drug–induced dystonia. Am J Psychiatry 132:532–534

    PubMed  Google Scholar 

  63. Thornberg SA, Ereshefsky L (1993) Neuroleptic malignant syndrome associated with clozapine monotherapy. Pharmacotherapy 13:510–514

    PubMed  CAS  Google Scholar 

  64. Vaamonde J, Artieda J, Obeso JA (1991) Hereditary paroxysmal ataxia with neuromyotonia. Mov Disord 6:180–182

    Article  PubMed  CAS  Google Scholar 

  65. Velamoor VR, Norman RM, Caroff SN, Mann SC, Sullivan KA, Antelo RE (1994) Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis 182:168–173

    Article  PubMed  CAS  Google Scholar 

  66. Von Brederlow B, Hahn AF, Koopman WJ, Ebers GC, Bulman DE (1995) Mapping the gene for acetazolamide responsive hereditary paroxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet 4:279–284

    Article  PubMed  CAS  Google Scholar 

  67. Wang HC, Hsieh Y (2001) Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy. Mov Disord 16:765–767

    Article  PubMed  CAS  Google Scholar 

  68. Washington C, Haines KA, Tam CW (1989) Amoxapine–induced neuroleptic malignant syndrome. DICP 23:713

    PubMed  CAS  Google Scholar 

  69. Weiner WJ, Lang AE (1989) Movement Disorders: A Comprehensive Survey. Futura Publishing, Mout Kisco, New York, pp 582–583

    Google Scholar 

  70. Weller M, Kornhuber J (1992) A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome. Med Hypotheses 38:329–333

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Neurology, Rostock University, Gehlsheimer Str. 20, 18147, Rostock, Germany

    D. Dressler MD, PhD & R. Benecke MD, PhD

Authors
  1. D. Dressler MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Benecke MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Dressler MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dressler, D., Benecke, R. Diagnosis and management of acute movement disorders. J Neurol 252, 1299–1306 (2005). https://doi.org/10.1007/s00415-005-0006-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0006-x

Key words

Search

Navigation